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In	December	2013,	during	a	Zika	virus	(ZIKV)	outbreak	in	
French	Polynesia,	 a	 patient	 in	Tahiti	 sought	 treatment	 for	
hematospermia,	 and	 ZIKV	 was	 isolated	 from	 his	 semen.	
ZIKV	 transmission	 by	 sexual	 intercourse	 has	 been	 previ-
ously	suspected.	This	observation	supports	 the	possibility	
that	ZIKV	could	be	transmitted	sexually.
Zika virus (ZIKV) is a mosquitoborne arbovirus in the family Flaviviridae, genus Flavivirus. It was first iso-
lated in 1947 from a rhesus monkey in the Zika forest of 
Uganda (1). Sporadic human cases were reported from the 
1960s in Asia and Africa. The first reported large outbreak 
occurred in 2007 on Yap Island, Federated States of Micro-
nesia (2). The largest known ZIKV outbreak reported start-
ed in October 2013 in French Polynesia, South Pacific (3), 
a territory of France comprising 67 inhabited islands; an 
estimated 28,000 persons (11% of the population) sought 
medical care for the illness (4). The most common symp-
toms of Zika fever are rash, fever, arthralgia, and conjuncti-
vitis. Most of the patients had mild disease, but severe neu-
rologic complications have been described in other patients 
in French Polynesia (5).
The Study
In early December 2013, during the ZIKV outbreak, a 
44-year-old man in Tahiti had symptoms of ZIKV infec-
tion: asthenia, low grade fever (temperature from 37.5°C to 
38°C) and arthralgia. Symptoms lasted 3 days. Eight weeks 
later, he described a second episode of symptoms compati-
ble with ZIKV infection: temperature from 37.5°C to 38°C, 
headache on days 1–3, and wrist arthralgia on days 5–7. 
The patient did not seek treatment, thus biological samples 
were not collected during the first 2 periods of illness. The 
patient fully recovered from the second episode, but 2 
weeks later he noted signs of hematospermia and sought 
treatment. Because the patient had experienced symptoms 
of ZIKV infection some weeks before, he was referred to 
our laboratory in the Institut Louis Malardé, Papeete, Ta-
hiti for ZIKV infection diagnostic testing. The medical 
questionnaire revealed no signs of urinary tract infection, 
prostatitis, urethritis, or cystitis, and the patient stated that 
he did not had any recent physical contact with persons 
who had acute ZIKV infection. We collected blood and se-
men samples. Direct and macroscopic examinations of the 
semen confirmed hematospermia. We extracted RNA us-
ing the NucliSENS easyMAG system (bioMérieux, Marcy 
l’Etoile, France) from 200 mL of blood and from 500 mL 
of semen and urine; both were eluted by 50 mL of elution 
buffer. We used 5 mL of RNA extracted for amplification. 
We tested blood and semen RNA extracts using real-time 
reverse transcription PCR (rRT-PCR) as described using 
2 primers/probe amplification sets specific for ZIKV (3). 
The rRT-PCR results were positive for ZIKV in semen 
and negative in blood, and confirmed by sequencing of 
the genomic position 858–1138 encompassing the prM/E 
protein coding regions of ZIKV. The generated sequence 
(GenBank accession no. KM014700) was identical to those 
previously reported at the beginning of the ZIKV outbreak 
(3). Three days later, we collected a urine sample, then a 
second set of blood and semen samples. Semen and urine 
from this second collection were not found to contain trac-
es of blood by both direct and macroscopic examinations. 
rRT-PCR detected ZIKV RNA in the semen and urine, but 
not in the blood sample.
We quantified ZIKV RNA loads using an RNA syn-
thetic transcript standard that covers the region targeted 
by the 2 primers/probe sets. RNA loads were: 2.9 × 107 
copies/mL and 1.1 × 107 copies/mL in the first and second 
semen samples, respectively, and 3.8 × 103 copies/mL in 
the urine sample.
We cultured semen and urine as described for den-
gue virus cultured from urine (6). Briefly, 200 mL of each 
sample diluted in 200 mL of 1% fetal calf serum (FCS) 
minimum essential medium (MEM) were inoculated onto 
Vero cells and incubated for 1 h at 37°C; inoculum was 
then removed and replaced by 1 mL of culture medium. 
We also inoculated a negative control (200 mL of 1% 
FCS-MEM) and a positive control (5 mL of a ZIKV-pos-
itive serum diluted in 200 mL of 1% FCS-MEM). The 
cells were then incubated at 37°C in 5% CO2 for 6 days. 
The presence of ZIKV in the culture fluids was detected 
by rRT-PCR as described.
Replicative ZIKV particles were found in the 2 semen 
samples but none were detected in the urine sample. This 
finding does not exclude the possibility that ZIKV particles 
were present in urine. Positive samples were not titered.
Conclusions
The ZIKV natural transmission cycle involves mosquitoes, 
especially Aedes spp. (7), but perinatal transmission (8) 
and potential risk for transfusion-transmitted ZIKV infec-
tions has also been demonstrated (9). Moreover, ZIKV 
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transmission by sexual intercourse has been suggested by 
Foy et al. (10), who described a patient who was infected 
with ZIKV in southeastern Senegal in 2008. After return-
ing to his home in Colorado, United States, he experienced 
common symptoms of ZIKV infection and symptoms of 
prostatitis. Four days later, he observed signs of hemato-
spermia, and on the same day, his wife had symptoms of 
ZIKV infection. Because the wife of the patient had not 
traveled out of the United States during the previous year 
and had sexual intercourse with him 1 day after he returned 
home, transmission by semen was suggested. ZIKV infec-
tion of the patient and his wife was confirmed by serologic 
testing, but the presence of ZIKV in the semen of the pa-
tient was not investigated.
Infectious organisms, especially sexually transmitted 
microorganisms including viruses (human papillomavirus 
or herpes simplex virus), are known to be etiologic agents 
of hematospermia (11). To our knowledge, before the re-
port of Foy et al. (10) and this study, arbovirus infections in 
humans had not been reported to be associated with hema-
tospermia, and no arboviruses had been isolated from hu-
man semen.
We detected a high ZIKV RNA load and replicative 
ZIKV in semen samples, but ZIKV remained undetect-
able by rRT-PCR in the blood sample collected at the same 
time. These results suggest that viral replication may have 
occurred in the genital tract, but we do not know when this 
replication started and how long it lasted. The fact that the 
patient had no common symptoms of ZIKV acute infection 
concomitantly to hematospermia suggests that the viremic 
phase occurred upstream, probably during the first or sec-
ond episode of mild fever, headache, and arthralgia.
The detection of ZIKV in both urine and semen is con-
sistent with the results obtained in a study of effects of Jap-
anese encephalitis virus, another flavivirus, on boars. The 
virus was isolated from urine and semen of experimentally 
infected animals, and viremia developed in female boars 
that artificially inseminated with the infectious semen (12).
Flaviviruses have also been detected in urine of per-
sons infected with West Nile virus (WNV). WNV RNA 
was detected in urine for a longer time and with higher 
RNA load than in plasma (13). WNV antigens were de-
tected in renal tubular epithelial cells, vascular endothelial 
cells, and macrophages of kidneys from infected hamsters 
(14), suggesting that persistent shedding of WNV in urine 
was caused by viral replication in renal tissue. Dengue vi-
rus (DENV) RNA and DENV nonstructural protein 1 an-
tigen were also detected in urine samples for a longer time 
than in blood, but infectious DENV has not been isolated 
in culture. Hirayama et al. concluded that the detection of 
DENV by rRT-PCR was useful to confirm DENV infec-
tions after the viremic phase (6). Also, yellow fever virus 
RNA was isolated from the urine of vaccinated persons 
(15), and Saint Louis encephalitis viral antigens, but not 
infective virus, have been detected in urine samples from 
infected patients (10).
Our findings support the hypothesis that ZIKV can be 
transmitted by sexual intercourse. Furthermore, the obser-
vation that ZIKV RNA was detectable in urine after viremia 
clearance in blood suggests that, as found for DENV and 
WNV infections, urine samples can yield evidence ofZIKV 
for late diagnosis, but more investigation is needed.
We obtained written informed consent from the patient for 
publication of this report, and publication of data related to 
ZIKV infections have been approved by the Ethics Committee of 
French Polynesia under reference 66/CEPF.
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